Search This Blog

Sunday, September 30, 2018

Cantor Fitzgerald Starts BioMarin (BMRN) at Overweight


Cantor Fitzgerald analyst Alethia Young initiates coverage on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) with a Overweight

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.